Nattokinase is a fibrinolytic enzyme extracted from natto, a traditional Japanese food made from fermented soybeans. Research suggests that nattokinase may support healthy blood circulation by helping to break down fibrin, a protein involved in blood clot formation, which has drawn interest for its potential role in cardiovascular wellness. Studies indicate that supplementation may also contribute to modest improvements in blood pressure regulation, particularly systolic blood pressure, though findings vary across populations and study designs. While nattokinase has a long history of dietary use in Japanese cuisine and a growing body of preliminary clinical research, it is worth noting that much of the evidence comes from smaller trials, and larger, long-term studies are still needed to fully understand its effects.
Compare this supplementResearch suggests that nattokinase may support blood circulation by breaking down fibrin and fibrinogen, the proteins...
View studies →Research suggests that nattokinase may support blood clot reduction through multiple mechanisms, including breaking d...
View studies →Research suggests that nattokinase may have potential relevance to blood pressure regulation, with laboratory evidenc...
View studies →Nattokinase is a strong fibrinolytic enzyme and combined with omega-3 blood-thinning effects may ...
View details →Nattokinase is a strong fibrinolytic enzyme; combined with ginkgo antiplatelet effects, bleeding ...
View details →Nattokinase is a potent fibrinolytic enzyme and curcumin has antiplatelet activity; combining the...
View details →Both have blood-thinning properties through different mechanisms; the combination may increase bl...
View details →Nattokinase has strong fibrinolytic activity and vitamin E has mild antiplatelet effects; combine...
View details →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 2,000 FU | Twice daily | atherosclerosis and lipid management | Dosing used in trials examining nattokinase effects on plaque reduction (e.g., Ero et al., 2013) |
| Capsule | 2,000–4,000 FU | Daily | blood circulation and clot prevention | Common range in clinical trials on fibrinolytic activity and cardiovascular markers |
| Capsule | 2,000 FU | Daily | blood pressure regulation | Used in RCTs examining nattokinase effects on hypertension (e.g., Kim et al., 2008, Hypertension Research) |
| Capsule | 100–200 mg | Daily | general cardiovascular support | mg-based dosing observed in trials; approximately corresponds to 2000 FU depending on standardization |